Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sartorius Stedim Biotech SA    STDM   FR0000053266

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period December 201420152016201720182019
Sales6848841 0521 0971 1691 295
EBITDA161231289295324371
Operating profit (EBIT)120185226240262299
Pre-Tax Profit (EBT)105170213247276335
Net income72,5139177169181210
P/E ratio34,239,031,228,725,421,7
EPS ( € )0,791,511,921,852,092,45
Dividend per Share ( € )0,220,330,420,410,600,56
Yield0,81%0,56%0,70%0,77%1,13%1,06%
Reference price ( € )26.883358.959.9753.253.253.2
Announcement Date01/27/2015
04:00pm
02/01/2016
06:00am
01/30/2017
06:00am
---
Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period December 201420152016201720182019
Debt87,486,459,098,960,2-
Finance-----14,5
Operating income (EBITDA)161231289295324371
Leverage
(Debt/EBITDA)
0,54x0,37x0,20x0,34x0,19x-
Capital Expenditure47,153,079,7112110106
Book Value Per Share (BVPS)5,78 €6,96 €8,22 €9,74 €11,4 €13,3 €
Cash Flow per Share1,21 €1,52 €1,70 €2,31 €2,53 €2,85 €
Announcement Date01/27/2015
04:00pm
02/01/2016
06:00am
01/30/2017
06:00am
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 4 904 M€ -
Entreprise Value (EV) 5 003 M€ 4 964 M€
Valuation 2017e 2018e
P/E ratio (Price / EPS) 28,7x 25,4x
Capitalization / Revenue 4,47x 4,19x
EV / Revenue 4,56x 4,25x
EV / EBITDA 17,0x 15,3x
Yield (DPS / Price) 0,77% 1,13%
Price to book (Price / BVPS) 5,46x 4,68x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 21,9% 22,4%
operating Leverage (Delta EBIT / Delta Sales) 1,43x 1,39x
Net Margin (Net Profit / Revenue) 15,4% 15,5%
ROA (Net Profit / Asset) 11,6% 11,7%
ROE (Net Profit / Equities) 19,5% 18,3%
Rate of Dividend 22,1% 28,8%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   10,2% 9,38%
Cash Flow / Sales 19,4% 19,9%
Capital Intensity (Assets / Sales) 1,33x 1,32x
Financial Leverage (Net Debt / EBITDA) 0,34x 0,19x
EPS & Dividend